Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Features

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Yael L. Maxwell

January 21, 2022

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Todd Neale

December 14, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Shelley Wood

January 04, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

Advertisement

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Roughly 80% of ESC Guideline Writers Have Financial COIs

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content